Applied Crowd Science

This text on the theory and applications of crowd safety provides the background and applications of crowd risk assessment tools, with case studies on www.routledge.com/9781138626560. It overviews legislation and guidance for crowd safety in places of public assembly, and the requirements of a crowd risk assessment for mass gatherings.

Applied Crowd Science outlines the theory and applications of the crowd safety course that Keith Still has developed and taught worldwide for over thirty years. It includes the background and applications of the crowd risk assessment tools, as well as essays and case studies from international users (UK, Ireland, Canada, Australia, Holland, Belgium and Japan) -- see Support Material on www.routledge.com/9781138626560. Keith's courses are mandatory training for all UK Police Public Event Commanders.

The text covers legislation and guidance for crowd safety in places of public assembly, and outlines the requirements of a crowd risk assessment for mass gatherings. It draws on Prof. Still's expert witness experience, highlighting both the problems you need to understand for your event planning.

Autorentext

Prof. Keith Still has been consulted on the world's largest and most challenging crowd safety projects. He was consulted on crowd safety for the Annual Pilgrimage to Makkah (Hajj), Olympic events the UK Royal Wedding, international festivals and mass gatherings. His opinion is sought by government and safety regulators around the world. He develops and teaches crowd safety and crowd risk analysis courses from Level 3 through to Level 7 (MSc).

Inhalt

1. Virtual Learning Environment (VLE). 2. The DIM-ICE Risk Model. 3. Crowd Dynamics. 4. Crowd Modelling. 5. RAMP Analysis. 6. Crowd Counting. 7. Control Room Information. 8. Queueing Systems. 9. Crowd Risk Analysis. 10. Event Egress Analysis. 11. Strategic and Tactical Analysis. 12. Emergency Situations. 13. Summary. 14. Crowd Science Essay's. 15. Selected Case Studies Using Crowd Science. 16. Crowd Science and Covid 19. 17. The Future.